Nicole E. Kucine

Hematology | Oncology
525 E 68th St # 695
New York, NY 10065

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism.

ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism.

Journal: Blood advances
Published: December 16, 2025

ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism.

ASH/ISTH 2026 guidelines for anticoagulant prophylaxis in pediatric patients at risk of venous thromboembolism.

Journal: Blood advances
Published: December 16, 2025

ASH ISTH 2026 guidelines for Anticoagulant Prophylaxis of Pediatric Patients at Risk of Venous Thromboembolism.

ASH ISTH 2026 guidelines for Anticoagulant Prophylaxis of Pediatric Patients at Risk of Venous Thromboembolism.

Journal: Blood advances
Published: December 16, 2025

Efficacy and safety of thrombolysis for pediatric venous thromboembolism: a systematic review and meta-analysis.

Efficacy and safety of thrombolysis for pediatric venous thromboembolism: a systematic review and meta-analysis.

Journal: Blood advances
Published: May 07, 2025

American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients.

American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients.

Journal: Blood advances
Published: November 14, 2024

A Toolkit for Healthcare Transition for Adolescents With Classical Myeloproliferative Neoplasms.

A Toolkit for Healthcare Transition for Adolescents With Classical Myeloproliferative Neoplasms.

Journal: Pediatric blood & cancer
Published: October 10, 2024

Heartbreaker.

Heartbreaker.

Journal: JAMA oncology
Published: September 26, 2024

Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial.

Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial.

Journal: Blood advances
Published: August 02, 2024

Clinical characteristics, treatment, and outcomes of provoked acute cerebral sinovenous thrombosis in patients <21 years old: findings from the Kids-DOTT Multinational Trial.

Clinical characteristics, treatment, and outcomes of provoked acute cerebral sinovenous thrombosis in patients <21 years old: findings from the Kids-DOTT Multinational Trial.

Journal: Research and practice in thrombosis and haemostasis
Published: May 31, 2024

Increased frequency of clonal hematopoiesis of indeterminate potential in Bloom syndrome probands and carriers.

Increased frequency of clonal hematopoiesis of indeterminate potential in Bloom syndrome probands and carriers.

Journal: Haematologica
Published: March 20, 2024

Increased Frequency of Clonal Hematopoiesis of Indeterminate Potential in Bloom Syndrome Probands and Carriers.

Increased Frequency of Clonal Hematopoiesis of Indeterminate Potential in Bloom Syndrome Probands and Carriers.

Journal: medRxiv : the preprint server for health sciences
Published: February 19, 2024

Cytoreductive therapy in younger adults with polycythemia vera: a meta-analysis of safety and outcomes.

Cytoreductive therapy in younger adults with polycythemia vera: a meta-analysis of safety and outcomes.

Journal: Blood advances
Published: December 19, 2023
Showing 1-12 of 35

Last Updated: 09/26/2026